Literature DB >> 27540512

Automated tru-cut imaging-guided core needle biopsy of canine orbital neoplasia. A prospective feasibility study.

A Cirla1, M Rondena1, G Bertolini2.   

Abstract

The purpose of this study was to evaluate the diagnostic value of imaging-guided core needle biopsy for canine orbital mass diagnosis. A second excisional biopsy obtained during surgery or necropsy was used as the reference standard. A prospective feasibility study was conducted in 23 canine orbital masses at a single centre. A complete ophthalmic examination was always followed by orbital ultrasound and computed tomography (CT) examination of the head. All masses were sampled with the patient still on the CT table using ultrasound (US) guided automatic tru-cut device. The most suitable sampling approach to the orbit was chosen each time based on the CT image analysis. One of the following different approaches was used: trans-orbital, trans-conjunctival or trans-masseteric. In all cases, the imaging-guided biopsy provided a sufficient amount of tissue for the histopathological diagnosis, which concurred with the biopsies obtained using the excisional technique. CT examination was essential for morphological diagnosis and provided detailed topographic information that allowed us to choose the safest orbital approach for the biopsy. US guided automatic tru-cut biopsy based on CT images, performed with patient still on the CT table, resulted in a minimally invasive, relatively easy, and accurate diagnostic procedure in dogs with orbital masses.

Entities:  

Keywords:  Computed tomography; Core-needle biopsy; Dogs; Orbital mass; Ultrasound

Year:  2016        PMID: 27540512      PMCID: PMC4980476          DOI: 10.4314/ovj.v6i2.7

Source DB:  PubMed          Journal:  Open Vet J        ISSN: 2218-6050


  36 in total

1.  Retrobulbar tumors in dogs and cats: 25 cases.

Authors:  K Attali-Soussay; J P Jegou; B Clerc
Journal:  Vet Ophthalmol       Date:  2001-03       Impact factor: 1.644

2.  Orbital mass lesions: US-guided fine-needle aspiration biopsy--experience in 37 patients.

Authors:  S Gupta; B Sood; M Gulati; D Takhtani; R Bapuraj; N Khandelwal; U Singh; A Rajwanshi; S Gupta; S Suri
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

3.  Ultrasound-guided Tru-cut biopsy of the breast.

Authors:  N P Woodcock; I Glaves; D R Morgan; J MacFie
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

4.  Minimally invasive anterior orbitotomy biopsy: finger's aspiration cutter technique (FACT).

Authors:  Paul T Finger
Journal:  Eur J Ophthalmol       Date:  2012 May-Jun       Impact factor: 2.597

Review 5.  Does the taking of biopsies affect the metastatic potential of tumours? A systematic review of reports on veterinary and human cases and animal models.

Authors:  R Klopfleisch; C Sperling; O Kershaw; A D Gruber
Journal:  Vet J       Date:  2011-07-01       Impact factor: 2.688

6.  Fine-needle aspiration cytology and immunocytochemistry of orbital masses.

Authors:  Edneia Tani; Stefan Seregard; George Rupp; Veli Söderlund; Lambert Skoog
Journal:  Diagn Cytopathol       Date:  2006-01       Impact factor: 1.582

7.  Diagnosis, treatment and outcome of orbital neoplasia in dogs: a retrospective study of 44 cases.

Authors:  D V Hendrix; K N Gelatt
Journal:  J Small Anim Pract       Date:  2000-03       Impact factor: 1.522

8.  Ultrasonically guided percutaneous fine needle aspiration biopsy of solid masses.

Authors:  G Phillips; M Schneider
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

9.  Orbital abscess bacterial isolates and in vitro antimicrobial susceptibility patterns in dogs and cats.

Authors:  Annie L Wang; Eric C Ledbetter; Thomas J Kern
Journal:  Vet Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.644

10.  CORE needle biopsy of orbital tumors.

Authors:  Andrey A Yarovoy; Evgeniya S Bulgakova; Anna V Shatskikh; Dzhulietta G Uzunyan; Svetlana S Kleyankina; Olesya V Golubeva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.